Ehud Shmuel Klein is a notable inventor based in Givat Savyon, Israel. He has made significant contributions to the field of pharmaceutical formulations, particularly those involving hyaluronic acid. With a total of 11 patents to his name, Klein's work has the potential to impact the treatment of various skin conditions.

Latest Patents

Klein's latest patents focus on formulations containing hyaluronic acid. One of his notable inventions is a method of treating diseases or conditions by administering a pharmaceutical composition topically to the skin or exposed tissue. This composition includes a therapeutically effective amount of a drug and a form of hyaluronic acid that facilitates the transport of the drug into the epidermis. Another patent involves pharmaceutical compositions that allow for effective non-toxic dosage amounts to be applied to the skin, ensuring that the drug reaches the site of the disease or condition for prolonged therapeutic effects.

Career Highlights

Klein is associated with Hyal Pharmaceutical Corporation, where he continues to develop innovative solutions in the pharmaceutical industry. His work emphasizes the importance of non-toxic formulations that can effectively treat skin conditions while ensuring patient safety.

Collaborations

Klein has collaborated with notable professionals in his field, including Samuel Simon Asculai and David Hochman. These collaborations have likely contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Ehud Shmuel Klein's contributions to pharmaceutical formulations, particularly those involving hyaluronic acid, demonstrate his commitment to innovation in the field. His patents reflect a dedication to improving treatment options for skin conditions, showcasing the potential for significant advancements in patient care.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com